CUL4B orchestrates mesenchymal stem cell commitment by epigenetically repressing KLF4 and C/EBPδ

Abstract

Dysregulated lineage commitment of mesenchymal stem cells (MSCs) contributes to impaired bone formation and an imbalance between adipogenesis and osteogenesis during skeletal aging and osteoporosis. The intrinsic cellular mechanism that regulates MSC commitment remains unclear. Here, we identified Cullin 4B (CUL4B) as a critical regulator of MSC commitment. CUL4B is expressed in bone marrow MSCs (BMSCs) and downregulated with aging in mice and humans. Conditional knockout of Cul4b in MSCs resulted in impaired postnatal skeletal development with low bone mass and reduced bone formation. Moreover, depletion of CUL4B in MSCs aggravated bone loss and marrow adipose accumulation during natural aging or after ovariectomy. In addition, CUL4B deficiency in MSCs reduced bone strength. Mechanistically, CUL4B promoted osteogenesis and inhibited adipogenesis of MSCs by repressing KLF4 and C/EBPδ expression, respectively. The CUL4B complex directly bound to Klf4 and Cebpd and epigenetically repressed their transcription. Collectively, this study reveals CUL4B-mediated epigenetic regulation of the osteogenic or adipogenic commitment of MSCs, which has therapeutic implications in osteoporosis.

References

[1] Pittenger MF et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284: 143-147

[2] Hu L et al. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int. J. Mol. Sci., 2018, 19: 360

[3] Chen Q et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ., 2016, 23: 1128-1139

[4] Valenti MT, Dalle Carbonare L, Mottes M. Osteogenic differentiation in healthy and pathological conditions. Int. J. Mol. Sci., 2016, 18: 41

[5] Justesen J et al. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology, 2001, 2: 165-171

[6] Li CJ et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Invest., 2015, 125: 1509-1522

[7] Wu Z, Bucher NL, Farmer SR. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol. Cell Biol., 1996, 16: 4128-4136

[8] Farmer SR. Transcriptional control of adipocyte formation. Cell Metab., 2006, 4: 263-273

[9] Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell Biochem., 2006, 99: 1233-1239

[10] Nakashima K et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 2002, 108: 17-29

[11] Kim JH et al. Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts. J. Cell Biol., 2014, 204: 1063-1074

[12] Birsoy K, Chen Z, Friedman J. Transcriptional regulation of adipogenesis by KLF4. Cell Metab., 2008, 7: 339-347

[13] Jackson S, Xiong Y. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem. Sci., 2009, 34: 562-570

[14] Tarpey PS et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet., 2007, 80: 345-352

[15] Zou Y et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet., 2007, 80: 561-566

[16] Li P et al. Lack of CUL4B in adipocytes promotes PPARgamma-mediated adipose tissue expansion and insulin sensitivity. Diabetes, 2017, 66: 300-313

[17] Mendez-Ferrer S et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 2010, 466: 829-834

[18] Benisch P et al. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One, 2012, 7: e45142

[19] Logan M et al. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis, 2002, 33: 77-80

[20] Uder C, Bruckner S, Winkler S, Tautenhahn HM, Christ B. Mammalian MSC from selected species: Features and applications. Cytometry A, 2018, 93: 32-49

[21] Li J et al. TGFbeta-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis. Nat. Commun., 2019, 10

[22] Hu H et al. CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis. Cancer Cell, 2012, 22: 781-795

[23] Ji Q et al. CRL4B interacts with and coordinates the SIN3A-HDAC complex to repress CDKN1A and drive cell cycle progression. J. Cell Sci., 2014, 127: 4679-4691

[24] Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev., 2000, 21: 115-137

[25] Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME. Playing with bone and fat. J. Cell Biochem., 2006, 98: 251-266

[26] Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells, 2020, 9: 2073

[27] Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem., 1996, 271: 31384-31390

[28] Ton-That H, Kaestner KH, Shields JM, Mahatanankoon CS, Yang VW. Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett., 1997, 419: 239-243

[29] Michikami I et al. Kruppel-like factor 4 regulates membranous and endochondral ossification. Exp. Cell Res., 2012, 318: 311-325

[30] Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem., 1998, 273: 30057-30060

[31] Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev., 1991, 5: 1538-1552

[32] Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J., 1997, 16: 7432-7443

[33] Nakayama N et al. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage. Development, 2004, 131: 229-240

[34] Albers J et al. Control of bone formation by the serpentine receptor Frizzled-9. J. Cell Biol., 2011, 192: 1057-1072

[35] Zhang H, Chen X, Sairam MR. Novel genes of visceral adiposity: identification of mouse and human mesenteric estrogen-dependent adipose (MEDA)-4 gene and its adipogenic function. Endocrinology, 2012, 153: 2665-2676

[36] Jung H et al. Involvement of PTP-RQ in differentiation during adipogenesis of human mesenchymal stem cells. Biochem. Biophys. Res. Commun., 2009, 383: 252-257

[37] Mortada I, Mortada R. Epigenetic changes in mesenchymal stem cells differentiation. Eur. J. Med. Genet., 2018, 61: 114-118

[38] Marofi F et al. Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on tuning the epigenetic changes. J. Cell Physiol., 2019, 234: 15108-15122

[39] Vincent A, Van Seuningen I. Epigenetics, stem cells and epithelial cell fate. Differentiation, 2009, 78: 99-107

[40] Qiu J. Epigenetics: Unfinished symphony. Nature, 2006, 441: 143-145

[41] Yang Y et al. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing. Oncogene, 2015, 34: 104-118

[42] Cho YG et al. Genetic and epigenetic analysis of the KLF4 gene in gastric cancer. APMIS, 2007, 115: 802-808

[43] Nakahara Y et al. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia, 2010, 12: 20-27

[44] Jiang B et al. Lack of Cul4b, an E3 ubiquitin ligase component, leads to embryonic lethality and abnormal placental development. PLoS One, 2012, 7: e37070

[45] Jiang B et al. DMP1 C-terminal mutant mice recapture the human ARHR tooth phenotype. J. Bone Miner Res., 2010, 25: 2155-2164

[46] Zhu H et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc., 2010, 5: 550-560

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82171851)

National Key R&D Program of China (2022YFC2703700, 2022YFC2703701)

National Key R&D Program of China (2022YFC2703700, 2022YFC2703703) National Natural Science Foundation of China (31970781)

National Natural Science Foundation of China (31970559) Key Research and Development Program of Shandong Province (2016GSF201143) Young Scholars Program of Shandong University